|
Upon receipt, the device history record was reviewed, documenting that the device performed as expected during the device manufacturing.In a next step the icd was subjected to an electrical analysis.First, the current consumption of the device was analyzed and found to be normal and as expected.Subsequently, the ability of the device to deliver therapies was verified.The antitachycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.A fibrillation signal was applied and the device detected the fibrillation signal as specified and started the charging of a defibrillation shock.However, the charging was aborted due a depleted battery.Therefore, the icd was opened and the inner assembly was inspected.The visual inspection of the inner assembly showed no anomalies.The electronic module was attached to an external power supply to check its functionality.There was no indication of a malfunction, particularly all therapy functions were available and worked as expected.Therefore, the battery was sent to the manufacturer for further analysis.The manufacturing records of the battery were inspected, documenting that the battery parameters were within specification during the battery manufacturing.No anomalies were documented during the production process, associated with this battery.The visual inspection of the battery did not reveal any external signs of damage.The voltage measurement confirmed the battery depletion.In a next step, the battery was opened for destructive analysis.The inspection of the inner assembly identified damaged insulation, which led to an increased internal self depletion within the battery and therefore contributed to the clinical observation.In conclusion, the device was implanted for 40 months.The therapeutic functionality of the device was tested with an attached external power supply and proved to be fully functional.The analysis revealed an increased internal self-depletion within the battery that contributed to the clinical observation.
|
|
This device reported eri status on (b)(6) 2019.In (b)(6) of 2018, in office interrogation showed battery longevity of 85%.The device was explanted on (b)(6) 2019 due to eri.Based on the analysis results received from the manufacturer on (b)(4) 2019, this event is reportable.
|